Hepatic Pseudolymphoma Mimicking Neoplasia in Primary Biliary Cholangitis: A Case Report
Article Sidebar
Main Article Content
Abstract
Visualizing a nodule in the liver parenchyma of a patient with chronic liver disease raises the suspicion of hepatic malignancy. We report here the case of a 63-year-old female with primary biliary cholangitis (PBC) in whom a hepatic pseudolymphoma (HPL) was incidentally detected. This fairly rare lesion mimics primary liver cancer, has no specific radiological features, and requires histology for a definite diagnosis. This tumor-like lymphoid liver proliferation has been reported in clinical situations with immune-mediated inflammation including PBC. It can be observed in many organs but very rarely in the liver. The diagnosis of HPL should be considered when detecting a liver nodule in a patient with this particular chronic cholestatic liver disease.
Article Details
Copyright (c) 2024 Hassoun J, et al.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Jones DE, Bassendine MF. Primary biliary cirrhosis. J Intern Med 1997;241:345-8. Available from: https://doi.org/10.1016/s0168-8278(99)80097-x
Wendum D, Boelle PY, Bedossa P, Zafrani ES, Charlotte F, Saint-Paul MC, et al. Primary biliary cirrhosis: proposal for a new simple histological scoring system. Liver Int 2015;35:652-9. Available from: https://doi.org/10.1111/liv.12620
Panjala C, Talwalkar JA, Lindor KD. Risk of lymphoma in primary biliary cirrhosis. Clin Gastroenterol Hepatol 2007;5:761-4. Available from: https://doi.org/10.1016/j.cgh.2007.02.020
Okada T, Mibayashi H, Hasatani K, Hayashi Y, Tsuji S, Kaneko Y, et al. Pseudolymphoma of the liver associated with primary biliary cirrhosis: a case report and review of literature. World J Gastroenterol 2009;15:4587-92. Available from: https://doi.org/10.3748/wjg.15.4587
Jones DE, Metcalf JV, Collier JD, Bassendine MF, James OF. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes. Hepatology 1997;26:1138-42. Available from: https://doi.org/10.1002/hep.510260508
Schonau JWASJH, H. Risk of cancer and subsequent mortality in primary biliary cholangitis: a population-based cohort study of 3052 patients. Gastro Hep Advances 2023;2:879-888. Available from: https://doi.org/10.1016/j.gastha.2023.05.004
Natarajan Y, Tansel A, Patel P, Emologu K, Shukla R, Qureshi Z, et al. Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis. Dig Dis Sci 2021;66:2439-2451. Available from: https://doi.org/10.1007/s10620-020-06498-7
Kwon YK, Jha RC, Etesami K, Fishbein TM, Ozdemirli M, Desai CS. Pseudolymphoma (reactive lymphoid hyperplasia) of the liver: A clinical challenge. World J Hepatol 2015;7:2696-702. Available from: https://doi.org/10.4254/wjh.v7.i26.2696
Inoue M, Tanemura M, Yuba T, Miyamoto T, Yamaguchi M, Irei T, et al. A case of hepatic pseudolymphoma in a patient with primary biliary cirrhosis. Clin Case Rep 2019;7:1863-1869. Available from: https://doi.org/10.1002/ccr3.2378
Sim KK, Fernando T, Tarquinio L, Navadgi S. Hepatic reactive lymphoid hyperplasia-associated primary biliary cholangitis masquerading as a neoplastic liver lesion. BMJ Case Rep 2023;16. Available from: https://doi.org/10.1136/bcr-2023-254963
Jiang W, Wu D, Li Q, Liu CH, Zeng Q, Chen E, et al. Clinical features, natural history and outcomes of pseudolymphoma of liver: A case-series and systematic review. Asian J Surg 2023;46:841-849. Available from: https://doi.org/10.1016/j.asjsur.2022.08.113
Fukuo Y, Shibuya T, Fukumura Y, Mizui T, Sai JK, Nagahara A, et al. Reactive lymphoid hyperplasia of the liver associated with primary biliary cirrhosis. Med Sci Monit 2010;16:CS81-6. Available from: https://pubmed.ncbi.nlm.nih.gov/20581780/
Sato S, Masuda T, Oikawa H, Satoh T, Suzuki Y, Takikawa Y, et al. Primary hepatic lymphoma associated with primary biliary cirrhosis. Am J Gastroenterol 1999;94:1669-73. Available from: https://doi.org/10.1111/j.1572-0241.1999.01160.x